1. Hendra FN, Van Cann EM, Helder MN, Ruslin M, de Visscher JG, Forouzanfar T, et al. Global incidence and profile of ameloblastoma: A systematic review and meta-analysis. Oral Dis. 2020;26:12-21.

https://doi.org/10.1111/odi.13031

PMid:30614154 

2. Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: current etiopathological concepts and management. Oral Dis. 2018;24:307-16.

https://doi.org/10.1111/odi.12646

PMid:28142213 

3. Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, et al. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 2014;46:722-5.

https://doi.org/10.1038/ng.2986

PMid:24859340 PMCid:PMC4418232

4. Rizzitelli A, Smoll NR, Chae MP, Rozen WM, Hunter-Smith DJ. Incidence and overall survival of malignant ameloblastoma. PLoS One. 2015;10:e0117789.

https://doi.org/10.1371/journal.pone.0117789

PMid:25692490 PMCid:PMC4333213

5. Almeida RDAC, Andrade ESDS, Barbalho JC, Vajgel A, Vasconcelos BCDE. Recurrence rate following treatment for primary multicystic ameloblastoma: Systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2016;45:359-67.

https://doi.org/10.1016/j.ijom.2015.12.016

PMid:26792147 

6. Guan P, Wong SF, Lim JQ, Ng CCY, Soong PL, Sim CQX, et al. Mutational Signatures in Mandibular Ameloblastoma Correlate with Smoking. J Dent Res. 2019;98:652-8.

https://doi.org/10.1177/0022034519837248

PMid:30917298 

7. Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, et al. Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res. 2014;20:5517-26.

https://doi.org/10.1158/1078-0432.CCR-14-1069

PMid:24993163 

8. Kurppa KJ, Catón J, Morgan PR, Ristimäki A, Ruhin B, Kellokoski J, et al. High frequency of BRAF V600E mutations in ameloblastoma. J Pathol. 2014;232:492-8.

https://doi.org/10.1002/path.4317

PMid:24374844 PMCid:PMC4255689

9. Niault TS, Baccarini M. Targets of Raf in tumorigenesis. Carcinogenesis. 2010;31:1165-74.

https://doi.org/10.1093/carcin/bgp337

PMid:20047953 

10. Hu S, Parker J, Wright JT. Towards unraveling the human tooth transcriptome: The dentome. PLoS One. 2015;10:e0124801.

https://doi.org/10.1371/journal.pone.0124801

PMid:25849153 PMCid:PMC4388651

11. Hu S, Parker J, Divaris K, Padilla R, Murrah V, Wright JT. Ameloblastoma Phenotypes Reflected in Distinct Transcriptome Profiles. Sci Rep. 2016;6:30867.

https://doi.org/10.1038/srep30867

PMid:27491308 PMCid:PMC4974613

12. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26:589-95.

https://doi.org/10.1093/bioinformatics/btp698

PMid:20080505 PMCid:PMC2828108

13. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22:568-76.

https://doi.org/10.1101/gr.129684.111

PMid:22300766 PMCid:PMC3290792

14. Yang H, Wang K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat Protoc. 2015;10:1556-66.

https://doi.org/10.1038/nprot.2015.105

PMid:26379229 PMCid:PMC4718734

15. 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526:68-74.

https://doi.org/10.1038/nature15393

PMid:26432245 PMCid:PMC4750478

16. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285-91.

https://doi.org/10.1038/nature19057

PMid:27535533 PMCid:PMC5018207

17. Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv. 2019;531:210.

https://doi.org/10.1101/531210

PMid:

18. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310-5.

https://doi.org/10.1038/ng.2892

PMid:24487276 PMCid:PMC3992975

19. Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40:W452-7.

https://doi.org/10.1093/nar/gks539

PMid:22689647 PMCid:PMC3394338

20. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248-9.

https://doi.org/10.1038/nmeth0410-248

PMid:20354512 PMCid:PMC2855889

21. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.

https://doi.org/10.1186/1471-2105-9-559

PMid:19114008 PMCid:PMC2631488

22. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003;13:2498-504.

https://doi.org/10.1101/gr.1239303

PMid:14597658 PMCid:PMC403769

23. Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. Omi A J Integr Biol. 2012;16:284-7.

https://doi.org/10.1089/omi.2011.0118

PMid:22455463 PMCid:PMC3339379

24. Kurppa KJ, Catón J, Morgan PR, Ristimäki A, Ruhin B, Kellokoski J, et al. High frequency of BRAFV600E mutations in ameloblastoma. J Pathol. 2014;232:492-8.

https://doi.org/10.1002/path.4317

PMid:24374844 PMCid:PMC4255689

25. Yang Z, Zhuang L, Szatmary P, Wen L, Sun H, Lu Y, et al. Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma. Int J Med Sci. 2015;12:256-63.

https://doi.org/10.7150/ijms.10735

PMid:25798051 PMCid:PMC4366630

26. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68:820-3.

https://doi.org/10.1073/pnas.68.4.820

PMid:5279523 PMCid:PMC389051